Sanofi S.A., FR0000120578

Jefferies keeps EUR 100.00 target for Sanofi stock

Published on 10/15/2026 at 15:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi posts results on October 30, 2026. Sanofi stock costs EUR 72.73 on October 15, 2026 at 3:08 p.m. CEST, up 1.24 percent versus Xetra close.

Market position and upcoming date

On October 7, 2026, Jefferies kept its Buy rating and EUR 100.00 target for Sanofi.
Sanofi's third-quarter 2026 results are scheduled for October 30, 2026.
Sanofi stock costs EUR 72.73 at Lang & Schwarz on October 15, 2026 at 3:08 p.m. CEST, 1.24 percent above the Xetra close of October 14, 2026.
Sanofi has a P/E ratio of 22.41 and a market capitalization of EUR 87.0 billion.

Overhead flatlay of pharmaceutical objects on white surface including clear glass vials, a syringe, petri dish, test tubes, a pipette, and blue nitrile gloves — Sanofi FR0000120578 overhead flatlay of pharmaceutical vials, syringe, pipette, petri dish, and protective gloves, Illustration mit AI erstellt.

Jefferies kept its Buy rating and EUR 100.00 price target for Sanofi on October 7, 2026, leaving the target 37.49 percent above the Lang & Schwarz price, according to Wallstreet Online. Sanofi stock was trading at EUR 72.73 at Lang & Schwarz on October 15, 2026 at 3:08 p.m. CEST, up 1.24 percent versus the Xetra close of October 14, 2026 at EUR 71.84.

Third-quarter results arrive October 30

Sanofi's next scheduled corporate event is its third-quarter 2026 results webcast on October 30, 2026. The company announced the date in its October 6, 2026 release, which also said the results would be reviewed by management before a question-and-answer session, according to Sanofi.

Price is 20.21 percent below high

The euro quote sits 20.21 percent below its 52-week high of EUR 91.15 and 4.27 percent above its 52-week low of EUR 69.75, both as of October 15, 2026. Trading volume stood at 491,849 shares at 3:01 p.m. CEST, against an average volume of 2,020,757 shares. The market capitalization was EUR 87.0 billion on the same date.

P/E stands at 22.41

Sanofi's P/E ratio was 22.41 on October 15, 2026. Jefferies' EUR 100.00 target gives the stock a 37.49 percent distance to the target at the Lang & Schwarz price, while the upcoming October 30 results provide the next dated checkpoint for the valuation.

Comparison with peers

Sanofi (Euronext Paris, EUR): plus 1.24 percent, P/E 22.41, market capitalization EUR 87.0 billion.
GSK (LSE, GBp): plus 2.23 percent, P/E 15.58, market capitalization GBP 74.4 billion.
AstraZeneca (LSE, GBp): plus 2.80 percent, P/E 25.05, market capitalization GBP 196.1 billion.

Sanofi price stays above yearly low

Sanofi stock was trading at EUR 72.73 at Lang & Schwarz on October 15, 2026 at 3:08 p.m. CEST, up 1.24 percent versus the Xetra close of October 14, 2026 at EUR 71.84. The further course of trading is shown by the continuously updated real-time quote of Sanofi stock.